| # | % | |||||
|---|---|---|---|---|---|---|
| 3001 | NII HLDGS INC COM PAR 0.001 | 18,800 | 40,000 | 0.00% | ||
| 3002 | ZAFGEN INC COM | 11,100 | 35,000 | 0.00% | ||
| 3003 | APTEVO THERAPEUTICS INC COM | 14,191 | 35,000 | 0.00% | ||
| 3004 | TANDEM DIABETES CARE INC | 12,400 | 27,000 | 0.00% | ||
| 3005 | TRANSENTERIX INC | 20,000 | 26,000 | 0.00% | ||
| 3006 | DURECT CORP | 18,000 | 24,000 | 0.00% | ||
| 3007 | PENN WEST | 13,500 | 24,000 | 0.00% | ||
| 3008 | TROVAGENE INC COM NEW | 10,500 | 22,000 | 0.00% | ||
| 3009 | ANTHERA PHARMACEUTICALS I | 21,600 | 14,000 | 0.00% | ||
| 3010 | CYTRX CORP | 34,700 | 13,000 | 0.00% | ||
| 3011 | TRIANGLE PETE CORP | 42,945 | 10,000 | 0.00% | ||
| 3012 | ISHARES TR | 26 | 3,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001532155-17-000120, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
